Home

Save These Dates

"Game Day" • Wed, October 7, 2015
REGISTRATION »

"Stomp Out Parkinson's" • Mon, October 19, 2015
Online Registration Available on Monday, September 7th, 2015

All funds raised go toward Parkinson's Disease Research.

PDRS: Alison Monette

Nurse's Tip

Infrequent swallowing can lead to excess saliva build-up and drooling in people with Parkinson's disease. Medications and other treatments are available, but first try chewing sugarless gum. The gum triggers frequent swallowing, reducing the amount of saliva in the mouth.


Alison Monette, RN, BSN, MS
Deep Brain Stimulator Program Coordinator
Neurosciences Institute, Central DuPage Hospital

More Tips from Alison Monette »

PDRS Medical Director: Michael Rezak

PDRS Medical Director: Michael Rezak, M.D. Ph.D.

Dr. Michael Rezak, a neurologist and Movement Disorders specialist, also serves as the Medical Director of the PDRS and the APDA Midwest Information and Referral Center and National Young Onset Center. He practices exclusively at the Neurosciences Institute of Central DuPage Hospital where he heads the Movement Disorders Center and the Movement Disorders Functional Neurosurgery Program.

The long awaited release of the concentrated carbidopa/levodopa formulation delivered directly into the small bowel came on 1/12/15. This treatment will benefit many advanced PD patients who cannot undergo DBS surgery. Abbvie pharmaceuti...
The long delayed release of the long acting carbidopa/levodopa formulation came on 1/9/15.\r\nImpax pharmaceuticals has been quoted as expecting the drug to be in pharmacies by late February. Please see accompanying article below which was...
Recently, I have received a number of inquiries regarding PD patients who have scheduled surgical procedures and some who have required emergency surgery.  Special consideration must be given to any PD patient that requires any type of ...
Although heretofore little appreciated, there are several key vitamins and other substances that, if deficient or excessive, can have a significant deleterious effect on the PD patient’s immediate and long-term health and independence....
Doctors at some institutions along with device companies and hospitals are promoting performing DBS implantation with the patient completely asleep. Limited studies have been done with select patients to prove that this is possible. No s...
The FDA has approved droxidopa for the treatment of neurogenic orthostatic hypotension (NOH) in Parkinson’s disease (PD) patients as well as in those with other illnesses through its new accelerated approval process. It is approved as ...
 PARKINSON\'S DISEASE 101 • Introduction to Parkinson’s Disease\r\n Ongoing Event  •  Free to the Public  •  No Reservations Needed\r\nEverything you wanted to ask about Parkinson’s Disease. This educational session is des...
First, let me say that I have no idea what diagnoses Robin Williams had been given or what medications he had been taking before his tragic death. I don’t know his medical history or if he had seen a neurologist and how the diagnosis o...
In an important article published by Doherty et al. in JAMA Neurology (vol.70,No. 5, May, 2013), 5 unrelated cases of young onset parkinsonism with the parkin gene mutation were studied in detail, and compared to 5 PD patients and 4 norm...
Rytary™ (formerly known as IPX066), although not yet released, has been shown to be effective in treating both early and later stage Parkinson’s disease symptoms.  It is a unique formulation of carbidopa/levodopa due to its longer a...
 

Statements or expressions of opinion appearing herein are those of the authors and not necessarily those of the PDRS
and should not be relied upon as a substitute for seeking individual medical advice.

©2015 Parkinson's Disease Research Society (PDRS), Winfield, IL 60190  |  By eMarkeing Logic, Evanston, IL 60201